Morgan Stanley’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.54M | Buy |
727,714
+318,717
| +78% | +$4.18M | ﹤0.01% | 3489 |
|
|
2025
Q1 | $9M | Sell |
408,997
-27,433
| -6% | -$604K | ﹤0.01% | 3438 |
|
|
2024
Q4 | $11.7M | Buy |
436,430
+18,299
| +4% | +$489K | ﹤0.01% | 3283 |
|
|
2024
Q3 | $11.2M | Buy |
418,131
+168,157
| +67% | +$4.49M | ﹤0.01% | 3344 |
|
|
2024
Q2 | $4.5M | Sell |
249,974
-124,744
| -33% | -$2.25M | ﹤0.01% | 3976 |
|
|
2024
Q1 | $6.83M | Sell |
374,718
-75,640
| -17% | -$1.38M | ﹤0.01% | 3656 |
|
|
2023
Q4 | $4.93M | Buy |
450,358
+377,287
| +516% | +$4.13M | ﹤0.01% | 4383 |
|
|
2023
Q3 | $419K | Sell |
73,071
-27,322
| -27% | -$157K | ﹤0.01% | 5245 |
|
|
2023
Q2 | $778K | Buy |
100,393
+36,120
| +56% | +$280K | ﹤0.01% | 4980 |
|
|
2023
Q1 | $429K | Buy |
64,273
+3,972
| +7% | +$26.5K | ﹤0.01% | 5343 |
|
|
2022
Q4 | $539K | Sell |
60,301
-44,436
| -42% | -$397K | ﹤0.01% | 5207 |
|
|
2022
Q3 | $1.03M | Buy |
104,737
+57,773
| +123% | +$569K | ﹤0.01% | 4853 |
|
|
2022
Q2 | $374K | Buy |
46,964
+24,989
| +114% | +$199K | ﹤0.01% | 5565 |
|
|
2022
Q1 | $214K | Buy |
21,975
+4,798
| +28% | +$46.7K | ﹤0.01% | 5884 |
|
|
2021
Q4 | $262K | Buy |
17,177
+16,311
| +1,883% | +$249K | ﹤0.01% | 5916 |
|
|
2021
Q3 | $14K | Buy |
866
+404
| +87% | +$6.53K | ﹤0.01% | 7219 |
|
|
2021
Q2 | $10K | Buy |
+462
| New | +$10K | ﹤0.01% | 7227 |
|